Fig. 5

XF-hMAPC cells modestly accelerated wound closure by contraction. Brightfield overview images of the splinted wound on day (d) 0 (a, e, i), d4 (b, f, j), d8 (c, g, k), and d10 (d, h, l) after wounding of mice treated with Plasma-Lyte control (“CTRL”; a–d; black circles in m; n = 15), middle-dose XF-hMAPC cells (“XF2”; e–h; blue triangles in m; n = 16), or high-dose XF-hMAPC cells (“XF3”; i–l; red triangles in m; n = 16) and corresponding quantification in m. Data represent mean wound size expressed as % versus size at d0 ± S.E.M. (*P < 0.05 versus indicated condition by repeated-measures ANOVA). Scale bars: 2 mm in a–l